• Exchange: -
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Optimer Pharmaceuticals Inc



Optimer Pharmaceuticals Inc (OPTR:US) was acquired by CBST:US

Company Profile

Optimer Pharmaceuticals, Inc. discovers, develops, and commercializes anti infective products. Optimer's initial development efforts address products that treat gastrointestinal infections (GI), and related diseases, including diminished efficacy, serious adverse side effects, drug-to-drug interactions, difficult patient compliance, and bacterial resistance.

Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...
sec ||= nil